[go: up one dir, main page]

MXPA02010089A - Compuestos para modular la proliferacion celular. - Google Patents

Compuestos para modular la proliferacion celular.

Info

Publication number
MXPA02010089A
MXPA02010089A MXPA02010089A MXPA02010089A MXPA02010089A MX PA02010089 A MXPA02010089 A MX PA02010089A MX PA02010089 A MXPA02010089 A MX PA02010089A MX PA02010089 A MXPA02010089 A MX PA02010089A MX PA02010089 A MXPA02010089 A MX PA02010089A
Authority
MX
Mexico
Prior art keywords
compounds
cell proliferation
modulating cell
modulating
styrylacrylonitrile
Prior art date
Application number
MXPA02010089A
Other languages
English (en)
Inventor
Nigel Sharfe
Original Assignee
Hsc Res Dev Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hsc Res Dev Lp filed Critical Hsc Res Dev Lp
Publication of MXPA02010089A publication Critical patent/MXPA02010089A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen compuestos novedosos de estirilacrilonitrilo los cuales son utiles para tratar una variedad de padecimientos proliferativos celulares tales como el cancer. Los compuestos son de la formula (I).
MXPA02010089A 2000-04-13 2001-04-12 Compuestos para modular la proliferacion celular. MXPA02010089A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19693600P 2000-04-13 2000-04-13
PCT/CA2001/000516 WO2001079158A2 (en) 2000-04-13 2001-04-12 Compounds for modulating cell proliferation

Publications (1)

Publication Number Publication Date
MXPA02010089A true MXPA02010089A (es) 2004-08-19

Family

ID=22727358

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02010089A MXPA02010089A (es) 2000-04-13 2001-04-12 Compuestos para modular la proliferacion celular.

Country Status (17)

Country Link
US (3) US6800659B2 (es)
EP (1) EP1272457B9 (es)
JP (1) JP2003531133A (es)
CN (1) CN100413845C (es)
AT (1) ATE337296T1 (es)
AU (2) AU4820101A (es)
BR (1) BR0110087A (es)
CA (1) CA2406160A1 (es)
CY (1) CY1106447T1 (es)
DE (1) DE60122484T2 (es)
DK (1) DK1272457T3 (es)
ES (1) ES2267747T3 (es)
GB (1) GB2378948B (es)
MX (1) MXPA02010089A (es)
PT (1) PT1272457E (es)
RU (1) RU2277531C9 (es)
WO (1) WO2001079158A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800659B2 (en) 2000-04-13 2004-10-05 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
WO2003030895A1 (en) * 2001-10-11 2003-04-17 The Hospital For Sick Children Styryl acrylonitrile compounds and their use to promote myelopoiesis
GB2401363B (en) * 2002-01-18 2005-10-12 Hospital For Sick Children Compounds for modulating cell proliferation
AU2003273702A1 (en) * 2002-10-11 2004-05-04 The Hospital For Sick Children Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor
CH696238A5 (de) * 2003-06-30 2007-02-28 Lymphosign Inc Verfahren zur Herstellung von Zimtaldehydverbindungen.
US20070197660A1 (en) * 2003-07-30 2007-08-23 The Hospital For Sick Children Compounds for modulating cell proliferation
US7598419B2 (en) 2004-03-26 2009-10-06 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
US7202383B2 (en) 2004-09-14 2007-04-10 The Hospital For Sick Children Compounds useful for modulating abnormal cell proliferation
US7807719B2 (en) * 2004-09-14 2010-10-05 Chaim Roifman Compounds useful for modulating abnormal cell proliferation
CN103172662A (zh) 2004-10-25 2013-06-26 德克技术公司 作为抗肿瘤剂的异磷酰胺氮芥及其类似物的盐
WO2007006143A1 (en) * 2005-07-13 2007-01-18 The Hospital For Sick Children Compositions and methods for detecting transformed cells
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
EP2043606A2 (en) * 2006-06-13 2009-04-08 Elan Pharma International Limited Nanoparticulate kinase inhibitor formulations
KR101505415B1 (ko) 2007-04-06 2015-03-25 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
US8450337B2 (en) * 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
WO2013027694A1 (ja) * 2011-08-24 2013-02-28 国立大学法人京都大学 コンフォメーション病診断用分子イメージングプローブ

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125597A (en) 1964-03-17 chj oh
US2798881A (en) * 1954-11-12 1957-07-09 Du Pont 4-(aminoaryl)-1, 3-butadiene-2-carbonitriles and their preparation
US3047606A (en) * 1958-12-01 1962-07-31 Rohm & Haas Dialkyl 1-cyanovinylphosphonates, their preparation, and polymers and copolymers thereof
US3852683A (en) 1971-10-18 1974-12-03 Eastman Kodak Co Arylidene dye lasers
GB1572441A (en) * 1975-12-23 1980-07-30 Vickers Ltd Photopolymerisable polymers with free carboxyl groups and printing plates therefrom
US4601532A (en) 1983-05-09 1986-07-22 Minnesota Mining And Manufacturing Company Narrow band light absorbing filter
US4554238A (en) * 1984-03-20 1985-11-19 Minnesota Mining And Manufacturing Company Spectrally-sensitized imaging system
JPS60244595A (ja) 1984-05-18 1985-12-04 Ricoh Co Ltd 感熱記録材料
US4632895A (en) 1984-08-23 1986-12-30 Minnesota Mining And Manufacturing Company Diffusion or sublimation transfer imaging system
US4617373A (en) * 1985-02-15 1986-10-14 Eastman Kodak Company Condensation polymers and products therefrom
CA1275538C (en) 1985-08-16 1990-10-23 Wayne P. Pruett Colored unsaturated polyester material containing copolymerized methine dyes, and products therefrom
US4950467A (en) * 1986-11-14 1990-08-21 Ici Americas Inc. Ultraviolet radiation absorbing compositions
AU632992B2 (en) * 1987-12-24 1993-01-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
US5217999A (en) * 1987-12-24 1993-06-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Styryl compounds which inhibit EGF receptor protein tyrosine kinase
EP0335641B1 (en) 1988-03-28 1994-01-05 Teijin Limited Organic nonlinear optical substance
US5196147A (en) 1988-03-28 1993-03-23 Teijin Limited Organic nonlinear optical substance
JPH02193954A (ja) 1989-01-23 1990-07-31 Teijin Ltd 薄膜規則性構造体
JP2672363B2 (ja) 1989-03-29 1997-11-05 帝人株式会社 有機非線形光学材料
JPH03230127A (ja) 1990-02-05 1991-10-14 Teijin Ltd 芳香族非線形光学材料
JPH03259126A (ja) 1990-03-09 1991-11-19 Teijin Ltd 新規な芳香族非線形光学材料
US5418245A (en) * 1990-04-16 1995-05-23 Rhone-Poulenc Rorer International (Holdings) Inc. Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
JPH0436731A (ja) 1990-06-01 1992-02-06 Teijin Ltd 新規な芳香族系非線形光学材料
JPH0496026A (ja) 1990-08-13 1992-03-27 Teijin Ltd 非線形光学材料
DE59107068D1 (de) 1990-09-17 1996-01-25 Ciba Geigy Ag Druck- oder wärmeempfindliches Aufzeichnungsmaterial
JPH04198924A (ja) 1990-11-29 1992-07-20 Teijin Ltd 芳香族共役基を有する非線形光学材料
JPH04214387A (ja) 1990-12-12 1992-08-05 Teijin Ltd 記録媒体及び記録方法
ES2107557T3 (es) * 1991-12-10 1997-12-01 Shionogi & Co Derivado de acido hidroxamico a base de sulfonamida aromatica.
JPH05173206A (ja) 1991-12-20 1993-07-13 Teijin Ltd 配向非線形光学素子
JPH0695186A (ja) 1992-09-14 1994-04-08 Teijin Ltd 耐久性を有する非線形光学素子
JPH06135948A (ja) 1992-10-30 1994-05-17 Taiho Yakuhin Kogyo Kk スチレン誘導体又はその塩
US5712395A (en) 1992-11-13 1998-01-27 Yissum Research Development Corp. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
US5792771A (en) 1992-11-13 1998-08-11 Sugen, Inc. Quinazoline compounds and compositions thereof for the treatment of disease
US5763441A (en) * 1992-11-13 1998-06-09 Sugen, Inc. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
JPH06186599A (ja) 1992-12-16 1994-07-08 Teijin Ltd 配向安定性を有する非線形光学素子
IL107736A (en) * 1993-11-24 2001-01-11 Yissum Res Dev Co Pharmaceutical composition for the prevention of septic shock and for the treatment of chronic inflammatory diseases
US5700823A (en) 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
AU2096895A (en) 1994-03-07 1995-09-25 Sugen, Incorporated Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
US5656655A (en) 1994-03-17 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase
GB9406137D0 (en) * 1994-03-28 1994-05-18 Erba Carlo Spa N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
JP3230127B2 (ja) 1994-06-09 2001-11-19 三菱マテリアル株式会社 チップ材が高い接合強度を有する内燃機関タペット部材
US5789448A (en) * 1994-07-27 1998-08-04 Mitsubishi Chemical Corporation Benzoylethylene derivative
JPH09230585A (ja) 1995-02-01 1997-09-05 Toray Ind Inc 水なし平版印刷版原版
AU6112896A (en) * 1995-06-07 1996-12-30 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders
JP3259126B2 (ja) 1995-09-26 2002-02-25 富士通株式会社 リング伝送システム及び該システムのスケルチ方法
US5578416A (en) * 1995-11-20 1996-11-26 Eastman Kodak Company Cinnamal-nitrile dyes for laser recording element
US5990193A (en) * 1995-12-12 1999-11-23 University Of Pittsburgh Polymers for reversible photoinduced sol gel transitions
US5932580A (en) * 1997-12-01 1999-08-03 Yissum Research And Development Company Of The Hebrew University Of Jerusalem PDGF receptor kinase inhibitory compounds their preparation and compositions
EP1051383B1 (en) * 1998-02-06 2004-07-28 De Montfort University Hydroxylation activated prodrugs
US6800659B2 (en) 2000-04-13 2004-10-05 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation

Also Published As

Publication number Publication date
US20040072803A1 (en) 2004-04-15
GB2378948B (en) 2004-11-10
ES2267747T3 (es) 2007-03-16
EP1272457B9 (en) 2006-12-20
WO2001079158A3 (en) 2002-01-31
US6800659B2 (en) 2004-10-05
CN100413845C (zh) 2008-08-27
WO2001079158A2 (en) 2001-10-25
US20040209845A1 (en) 2004-10-21
DE60122484T2 (de) 2006-12-21
ATE337296T1 (de) 2006-09-15
AU4820101A (en) 2001-10-30
PT1272457E (pt) 2007-01-31
DK1272457T3 (da) 2007-01-08
RU2277531C9 (ru) 2006-11-20
CA2406160A1 (en) 2001-10-25
EP1272457A2 (en) 2003-01-08
RU2277531C2 (ru) 2006-06-10
US7012095B2 (en) 2006-03-14
RU2002127415A (ru) 2004-02-27
US20030109502A1 (en) 2003-06-12
CY1106447T1 (el) 2011-10-12
JP2003531133A (ja) 2003-10-21
HK1052496A1 (en) 2003-09-19
AU2001248201B2 (en) 2006-12-14
EP1272457B1 (en) 2006-08-23
BR0110087A (pt) 2004-02-17
DE60122484D1 (de) 2006-10-05
GB2378948A (en) 2003-02-26
CN1429202A (zh) 2003-07-09
GB0226316D0 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
GB2378948B (en) Novel compounds for modulating cell proliferation
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
NZ506329A (en) Inhibitors of phospholipase enzymes
MXPA05001354A (es) Piperidina-ftalazonas sustituidas por pirrolidinodiona como inhibidores pde4.
IL163607A0 (en) Amino-substituted 2,6-dialkoxystyryl 4-substitutedbenzylsulfones for treating proliferative disorders
DE60205776D1 (en) Indolinon-derivative als protein-kinasehemmer
PL414997A1 (pl) Zastosowanie 40-O-(2-hydroksyetylo)-rapamycyny do leczenia guzów litych nerki
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
AU2001292579A1 (en) Methods and compounds for treating proliferative diseases
AU1044500A (en) Imidazonaphthyridines
CY2538B1 (en) Tetrahydropyrido compounds
AP2001002220A0 (en) Calcilytic compounds.
PL365165A1 (en) Tricyclic imidazopyridines
IL138688A0 (en) Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
MY125674A (en) Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
IN187760B (es)
DE60011677D1 (en) Tryptase-inhibitoren
HUP0303312A3 (en) Polynucleotide useful for modulating cancer cell proliferation
SI1244614T1 (en) Tryptase inhibitors
AU2003224486A1 (en) Composition for treating cancer containing n,n-dimethylphytosphingosine
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
AU2003264707A1 (en) Use of a chrysanthellum extract
BG107553A (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same

Legal Events

Date Code Title Description
FG Grant or registration